In short. The verifiable professional profile of Yongbo Jia, MD (贾勇波), Head of Dermatology at Chongqing West District Hospital, and his focused practice in acne, pigmentation and rosacea.
Key points
- We publish only what can be checked: Dr.
- Jia’s name, his hospital role, his training, the academic roles below, and the clinical scope described here.
- No invented awards, no invented dates, no rankings, no case counts, and no claims about outcomes that cannot be supported.
Yongbo Jia, MD (贾勇波) is Head of Dermatology at Chongqing West District Hospital and Deputy Director of the hospital’s Plastic Surgery & Aesthetics Medical Center. This page states what can be verified about his role, his training and his clinical scope — and deliberately nothing more.
Role at Chongqing West District Hospital
Dr. Jia heads the dermatology service of the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital, a tertiary general hospital in Jiulongpo District, Chongqing. He works within a four-physician leadership team: Shaoliang Wang (王韶亮), who serves as Center Director; Tongchun Mao (毛彤春); Ke He (何锞); and Dr. Jia himself. His place in that team is the medical skin work — the diagnosis, the medical control of inflammatory disease, and the skin health that every other treatment depends on.
Training and credentials
Dr. Jia is a vice chief physician and a licensed aesthetic attending. He graduated from Chengdu University of Traditional Chinese Medicine, and trained in dermatology at the Institute of Dermatology of the Chinese Academy of Medical Sciences and at Chongqing Hospital of Traditional Chinese Medicine. His academic and professional roles are listed below exactly as they stand.
Focused scope: acne, pigmentation and rosacea
This site covers one deliberately narrow part of his practice: acne, pigmentation and rosacea. That scope is narrower than general dermatology, and the reasons are clinical rather than commercial. These three groups of conditions are the ones patients most often treat wrongly for years — buying products instead of getting a diagnosis, or abandoning a plan three weeks before it would have worked.
Acne is a disease of the pilosebaceous unit, driven by hormones and genetics, and it is chronic and relapsing. Treatment is judged at eight to twelve weeks, not at two. Isotretinoin carries real risks and requires monitoring; it is not a casual choice. Melasma is a pigmentary condition that is managed rather than cured, and it returns when photoprotection stops. Acne scars are improved by treatment rather than erased by it. Rosacea is controllable over years, and its triggers are individual. Getting those limits stated honestly at the start is part of the treatment.
What “verifiable” means on this site
We publish only what can be checked: Dr. Jia’s name, his hospital role, his training, the academic roles below, and the clinical scope described here. No invented awards, no invented dates, no rankings, no case counts, and no claims about outcomes that cannot be supported.
How care is organised
Care begins with an assessment: what the diagnosis actually is, what has already been tried, what the patient wants from treatment, and what the realistic timeline looks like. Acne is then treated in steps, with the medical control of active lesions first, the aftercare of marks second, and scar treatment only once the acne is quiet. Where a hormonal pattern raises specific concerns, endocrine assessment is arranged. Where a lesion needs surgical removal, the hospital’s own pathology and surgical services are in the same building.
Arrange an assessment rather than waiting if
- Acne is nodular, painful, or already leaving marks and dents — early control limits permanent damage.
- A correct routine has been used consistently for two to three months without improvement.
- Pigmentation is spreading, a redness condition is affecting the eyes, or the condition is affecting mood and daily life.
Frequently asked questions
Why is this site limited to acne, pigmentation and rosacea?
Because these are the conditions patients most often treat wrongly for years, buying products instead of getting a diagnosis, or abandoning a plan three weeks before it would have worked. The narrower scope allows the limits and timescales of each to be stated honestly.
How is care sequenced at the clinic?
Assessment comes first: what the diagnosis actually is, what has already been tried, what the patient wants from treatment, and the realistic timeline. Active acne is then controlled medically, marks are managed second, and scar treatment begins only once the acne is quiet.
When should acne be assessed rather than waited out?
When it is nodular, painful or already leaving marks and dents, because early control limits permanent damage; when a correct routine has been used consistently for two to three months without improvement; or when the condition is affecting mood and daily life.
Risks & Limitations
- Most chronic skin disease is managed rather than cured, and relapse is expected.
- Treatments typically need 8–12 weeks before response can be judged fairly.
- Topical treatment can cause irritation, dryness, peeling and photosensitivity.
- Systemic therapy may require blood monitoring and carries organ, metabolic and pregnancy risks.
- Isotretinoin in particular requires strict monitoring and pregnancy prevention.
- Pigment change is often slow and may be incomplete.
- No treatment works for everyone, and response cannot be predicted with certainty.
When to Seek Care
- A mole or lesion that changes in size, shape or colour, or starts to bleed, itch or crust.
- Fever with a widespread rash, blistering, or rash involving the eyes, mouth or genitals — seek emergency care.
- Rapidly spreading redness, swelling or pain in the skin.
- Facial swelling or difficulty breathing — possible severe reaction; seek emergency care immediately.
- New or worsening symptoms while taking a monitored medication.
References & Further Reading
- American Academy of Dermatology (AAD) — public and clinical guidance
- World Health Organization (WHO) — skin and infectious disease resources
- Chinese Medical Association, Dermatology Branch — clinical guidance
- Cochrane Library — systematic reviews in dermatology
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.